abstract |
The present invention relates to an immunogenic plasmid with excellent expression efficiency and immunopotency in SIVmac239 / rhesus monkey model. The invention also relates to DNA vaccines for the prevention or treatment of AIDS, which contain their immunogenic plasmids and optionally an adjuvant plasmid. |